Related Experiment Video
Updated: Jul 26, 2026
06:08
A Novel Method: Super-selective Adrenal Venous Sampling
Published on: September 15, 2017
Phaeochromocytomas presenting as acute crises after beta blockade therapy
L Sibal1, A Jovanovic, S C Agarwal
1Department of Endocrinology, Newcastle upon Tyne Acute Hospitals, Newcastle upon Tyne, UK. latika.sibal@ncl.ac.uk
Clinical Endocrinology
|August 5, 2006
Summary
Phæochromocytoma crisis, a rare emergency, often presents with non-specific symptoms. Early suspicion, especially with cardiopulmonary issues after beta-blocker use, is key for diagnosis and survival.
Area of Science:
- Endocrinology
- Cardiology
- Emergency Medicine
Background:
- Phæochromocytoma crisis is a life-threatening condition with diverse, non-specific symptoms, often leading to delayed diagnosis.
- This study retrospectively analyzes the presentation, management, and outcomes of patients admitted with phæochromocytoma crises.
Observation:
- Five undiagnosed phæochromocytoma patients presented with emergencies requiring intensive care.
- Presentations included cardiomyopathy, atypical pneumonia with myocarditis, and acute abdomen; only one had elevated blood pressure initially.
- Beta-blocker initiation worsened hemodynamic status in four patients, prompting phæochromocytoma diagnosis.
Findings:
- All five patients recovered with intensive supportive care and alpha blockade, followed by successful surgical removal of the phæochromocytoma.
- Delayed diagnosis of phæochromocytoma crisis is common due to its varied and nonspecific clinical manifestations.
Implications:
- Unexplained cardiopulmonary dysfunction, especially post-beta-blocker administration, should raise suspicion for phæochromocytoma.
- A high index of clinical suspicion is crucial for early diagnosis and aggressive management to reduce mortality and morbidity in phæochromocytoma crisis.
Related Concept Videos
01:30Adrenergic Agonists: Therapeutic Uses
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
01:22Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
α-Adrenergic antagonists, known as α-blockers, exert their effects by inhibiting α-adrenoceptors, leading to specific physiological actions. α1-blockers and α2-blockers have distinct pharmacological actions and therapeutic applications.
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally, α1-blockers effectively address urinary obstruction...
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally, α1-blockers effectively address urinary obstruction...
01:27Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in bronchial smooth...
01:27Adrenal Gland Disorders
Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
01:15Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
01:19Cushing Syndrome II: Pathophysiology
Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...